IFNL3 and Hepatic fibrosis: Likewise, other subject characteristics including gender, age, genetic polymorphisms (such as IL28B), and liver fibrosis status, all of which may affect immunity and responses to HCV infection (13, 66, 67) were not used as factors to subdivide patient groups in the downstream analysis.